News

Drug company lobbyist joins Oxfam's cheap drugs campaign

BMJ 2001; 322 doi: 10.1136/bmj.322.7293.1011/a (Published 28 April 2001)
Cite this as: BMJ 2001;322:1011.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Roger Dobson
  1. Abergavenny

    A senior lobbyist in the pharmaceutical industry is leaving his job to help to spearhead the battle for cheaper drugs to be made available in the developing world. David Earnshaw, director of European government affairs for SmithKline Beecham, will next month join Oxfam and lead its campaign on access to medicines.

    Oxfam has been at the forefront of the growing confrontation over the costs of drugs to the developing world, especially AIDS and HIV treatment, and Mr Earnshaw is highly critical …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular